Up | AC
Drugs Advisory Committee
January 23, 2008
Portions of this document have been determined to be exempt
from disclosure under the Freedom of Information Act (the
FOIA) (5 U.S.C. §552). These redacted portions will appear
as white space on the screen or on the printed page.
FDA Briefing Material (pdf)
The statements contained in this document(s) are those of
the product's sponsor, not FDA, and FDA does not necessarily agree with the
sponsor's statements. FDA has not made a final determination about the safety
or effectiveness of the product described in this document.
Entereg® (Alvimopam) Capsules, Adolor Corporation
Briefing Material (pdf)